iCo Therapeutics soars 14.3% March 01, 2017 17:00 EST
CANADIAN DAILY STOCK REPORT
iCo Therapeutics Inc. (TSXV:ICO), Canada's 51st largest Biotechnology company by market cap, has soared 0.50c (14.3%) from its last trading session of February 28 to close at 4.0c. Compared with the S&P/TSX 60 Index which rose 11.1 points (1.2%) in the day, the relative price increase was 13.1%. The volume was 0.1 times the average daily trading volume of 416,575 shares.
ICO THERAPEUTICS BULLISH SIGNALS